Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a clinical-stage biotechnology company. It is primarily engaged in research and development activities.
IPO Date: September 11, 2017
Sector: Healthcare
Industry: Biotech
Market Cap: $240.56M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.18 | 2.50%
Avg Daily Range (30 D): $0.17 | 2.05%
Avg Daily Range (90 D): $0.18 | 2.58%
Institutional Daily Volume
Avg Daily Volume: .09M
Avg Daily Volume (30 D): .05M
Avg Daily Volume (90 D): .07M
Trade Size
Avg Trade Size (Sh.): 126
Avg Trade Size (Sh.) (30 D): 80
Avg Trade Size (Sh.) (90 D): 96
Institutional Trades
Total Inst.Trades: 35
Avg Inst. Trade: $2.88M
Avg Inst. Trade (30 D): $.69M
Avg Inst. Trade (90 D): $.94M
Avg Inst. Trade Volume: .36M
Avg Inst. Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $6.2M
Avg Closing Trade (30 D): $.69M
Avg Closing Trade (90 D): $.69M
Avg Closing Volume: 755.98K
   
News
Jun 3, 2025 @ 8:31 PM
Fennec Announces Results of Annual Meeting
Source: N/A
Feb 7, 2025 @ 12:00 PM
Fennec Pharmaceuticals Announces Commercial Launch...
Source: Fennec Pharmaceuticals Inc.
Jul 1, 2024 @ 10:00 AM
Fennec Pharmaceuticals Announces Management Change...
Source: Fennec Pharmaceuticals Inc.
Jun 25, 2024 @ 8:35 PM
Fennec Announces Results of Annual Meeting
Source: Fennec Pharmaceuticals Inc.
May 14, 2024 @ 11:15 AM
Adherex Technologies Inc. (FENC) Lags Q1 Earnings ...
Source: Zacks Equity Research
Financials
  TTM Q1 2025 Q4 2024
Basic EPS $-.53 $-.04 $-.08
Diluted EPS $-.53 $-.04 $-.08
Revenue $ 30.91M $ 8.75M $ 7.93M
Gross Profit $ $ $
Net Income / Loss $ -14.44M $ -1.17M $ -1.99M
Operating Income / Loss $ -11.98M $ -.81M $ -.93M
Cost of Revenue $ $ $
Net Cash Flow $ M $ M $ M
PE Ratio    
Splits
Sep 05, 2014:   1:3
Aug 30, 2011:   1:18
Aug 02, 2005:   1:5